Posted by Michael Wonder on 05 Apr 2023
Global blockbusters’ failure to win insurance coverage raises questions about fairness
5 April 2023 - Here is a case in which patients' treatment options and companies' business rights have been put on the back burner.
That is the story of Evrysdi (risdiplam), the spinal muscular atrophy treatment developed by Roche.
